Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Andersen H, Wollenberger L, Halling-Sørensen B, Kusk K (2001) Development of copepod nauplii to copepodites-A parameter for chronic toxicity including endocrine disruption. Environ Toxicol Chem 20:2821–2829
Andersen O, Eijsink VGH, Thomassen M (2000) Multiple variants of the peroxisome proliferator-activated receptor (PPAR) gamma are expressed in the liver of Atlantic salmon (Salmo salar). Gene 255:411–418
Andreozzi R, Raffaele M, Nicklas P (2003) Pharmaceuticals in STP effluents and their solar photodegradation in aquatic environment. Chemosphere 50:1319–1330
Ankley GT et al. (2002) Evaluation of the aromatase inhibitor fadrozole in a short-term reproduction assay with the fathead minnow (Pimephales promelas). Toxicol Sci 67:121–130
Ashton D, Hilton M, Thomas KV (2004) Investigating the environmental transport of human pharmaceuticals to streams in the United Kingdom. Sci Total Environ 333:167–184
Baatrup E, Junge M (2001) Antiandrogenic pesticides disrupt sexual characteristics in the adult male guppy Poecilia reticulata. Environ Health Perspect 109:1063–1070
Banks AT, Zimmerman HJ, Ishak KG, Harter JG (1995) Diclofenac-associated hepatotoxicity: Analysis of 180 cases reported to the food and drug administration as adverse reactions. Hepatology 22: 820–827
Baronti C, Curini R, D’Ascenzo G, Di Corcia A, Gentili A, Samperi R (2000) Monitoring natural and synthetic estrogens at activated sludge sewage treatment plants and in a receiving river water. Environ Sci Technol 34:5059–5066
Bjorkman D (1998) Nonsteroidal anti-inflammatory drug-associated toxicity of the liver, lower gastrointestinal tract, and esophagus. Am J Med 105:17S–21S
Borgmann U, Bennie DT, Ball AL, Palabrica V (2006) Effect of a mixture of seven pharmaceuticals on Hyalella azteca over multiple generations. Chemosphere 66:1278–1283
Bound JP, Voulvoulis N (2004) Pharmaceuticals in the aquatic environment-a comparison of risk assessment strategies. Chemosphere 56:1143–1155
Boxall AB, Kolpin DW, Halling-Sørensen B, Tolls J (2003) Are veterinary medicines causing environmental risks? Environ Sci Technol 37:286A–294A
Boyd GR, Reemtsma H, Grimm DA, Mitra S (2003) Pharmaceuticals and personal care products (PPCPs) in surface and treated waters of Louisiana, USA and Ontario, Canada. Sci Total Environ. 311:135–149
Brain RA et al. (2004a) Microcosm evaluation of the effects of an eight pharmaceutical mixture to the aquatic macrophytes Lemna gibba and Myriophyllum sibiricum. Aquat Toxicol 70:23–40
Brain RA, Johnson DJ, Richards SM, Sanderson H, Sibley PK, Solomon KR (2004b) Effects of 25 pharmaceutical compounds to Lemna gibba using a seven-day static-renewal test. Environ Toxicol Chem 23:371–382
Brain RA, Reitsma TS, Lissemore LI, Bestari K, Sibley PK, Solomon KR (2006) Herbicidal effects of statin pharmaceuticals in Lemna gibba. Environ Sci Technol 40:5116–5123
Brian JV et al. (2005) Accurate prediction of the response of freshwater fish to a mixture of estrogenic chemicals. Environ Health Perspect 113:721–728
Brooks BW et al. (2003) Aquatic ecotoxicology of fluoxetine. Toxicol Lett 142:169–183
Brooks BW et al. (2005) Determination of select antidepressants in fish from an effluent-dominated stream. Environ Toxicol Chem 24:464–469
Buser HR, Poiger T, Müller MD (1998) Occurrence and fate of the pharmaceutical drug diclofenac in surface waters: rapid photodegradation in a lake. Environ Sci Technol 32:3449–3456
Buser HR, Poiger T, Müller MD (1999) Occurrence and environmental behavior of the chiral pharmaceutical drug ibuprofen in surface waters and in wastewater. Environ Sci Technol 33:2529–2535
Cajaraville MP, Cancio M, Ibabe A, Orbea A (2003) Peroxisome proliferation as a biomarker in environmental pollution assessment. Microsc Res Techniq 61:191–202
Calamari D, Zuccato E, Castiglioni S, Bagnati R, Fanelli R (2003) Strategic survey of therapeutic drugs in the rivers Po and Lambro in northern Italy. Environ Sci Technol 37:1241–1248
Calleja MC, Persoone G, Geladi P (1993) The predictive potential of a battery of ecotoxicological tests for human acute toxicity, as evaluated with the first 50 MEIC chemicals. ATLA-Altern Lab Anim 21:330–349
Calleja MC, Persoone G, Geladi P (1994) Comparative acute toxicity of the first 50 multicenter evaluations of in-vitro cytotoxicity chemicals to aquatic non-vertebrates. Arch Environ Con Tox 26:69–78
Caminada D, Escher C, Fent K (2006) Cytotoxicity of pharmaceuticals found in aquatic systems: comparison of PLHC-1 and RTG-2 fish cell lines. Aquat Toxicol 79:114–123
Carballa M et al. (2004) Behavior of pharmaceuticals, cosmetics and hormones in a sewage treatment plant. Water Res 38:2918–2926
Clara M, Strenn B, Kreuzinger N (2004) Carbamazepine as a possible anthropogenic marker in the aquatic environment: investigations on the behaviour of carbamazepine in wastewater treatment and during groundwater infiltration. Water Res 38:947–954
Cleuvers M (2003) Aquatic ecotoxicity of pharmaceuticals including the assessment of combination effects. Toxicol Lett 142:185–194
Cleuvers M (2004) Mixture toxicity of the anti-inflammatory drugs diclofenac, ibuprofen, naproxen, and acetylsalicylic acid. Ecotox Environ Safe 59:309–315
Cleuvers M (2005) Initial risk assessment for three [beta]-blockers found in the aquatic environment. Chemosphere 59:199–205
Cole LM, Lawrence LJ, Casida JE (1984) Similar properties of [35S]-butylbicyclophosphorothionate receptor and coupled components of the gaba receptor-ionophore complex in brains of human, cow, rat, chicken and fish. Life Sci 35:1755–1762
Cunningham VL, Buzby M, Hutchinson T, Mastrocco FJ, Parke NJ, Roden NM (2006) Effects of human pharmaceuticals on aquatic life: next steps. Environ Sci Technol 40:3456–3462
Damstra T, Barlow S, Bergman A, Kavlock R, van der Kraak G (2002) Global assessment of the state of the science of endocrine disruptors. WHO/PCS/EDC/02.2
Daughton CG, Ternes TA (1999) Pharmaceuticals and personal care products in the environment: agents of subtle change? Environ Health Persp 107:907–938
De Lange HJ, Noordoven W, Murk AJ, Lüring M, Peeters ETHM (2006) Behavioural responses of Gammarus pulex (Crustacea, Amphipoda) to low concentrations of pharmaceuticals. Aquat Toxicol 78:209–216
Debernard S, Rossignol F, Couillaud F (1994) HMG-CoA Reductase inhibitor fluvastatin inhibits insect juvenile-hormone biosynthesis. Gen Comp Endocr 95:92–98
Desbrow C, Routledge EJ, Brighty GC, Sumpter JP, Waldock M (1998) Identification of estrogenic chemicals in STW effluent. 1. Chemical fractionation and in vitro biological screening. Environ Sci Technol 32:1549–1558
Desvergne B, Wahli W (1999) Peroxisome proliferator-activated receptors: Nuclear control of metabolism. Endocr Rev 20:649–688
Doggrell SA (1990) The membrane stabilizing and beta1-adrenoceptor blocking activity of (+)- and (–)-propranolol on the rat left atria. Gen Pharmacol Vasc S 21:677–680
Donohue M, Baldwin LA, Leonard DA, Kostecki PT, Calabrese EJ (1993) Effect of hypolipidemic drugs gemfibrozil, ciprofibrate, and clofibric acid on peroxisomal [beta]-oxidation in primary cultures of rainbow trout hepatocytes. Ecotox Environ Safety 26:127–132
Dzialowski EM, Brooks BW, Turner PK, Huggett D (2003) Influence of beta-adrenergic blockers on Daphnia magna heart rate, respiration, and reproduction. In: Proceedings of the SETAC North America 23rd Annual Meeting, Austin, USA
Emblidge JP, DeLorenzo ME (2006) Preliminary risk assessment of the lipid-regulating pharmaceutical clofibric acid, for three estuarine species. Environ Res 100:216–226
EMEA (2006) Guideline on the environmental risk assessment of medicinal products for human use. EMEA/CHMP/SWP/4447/00.The European Agency for the evaluation of medicinal products (EMEA), London, 01 June 2006
Escriva H et al. (1997) Ligand binding was acquired during evolution of nuclear receptors. Proc Natl Acad Sci USA 94:6803–6808
FDA-CDER (1998) Guidance for industry-Environmental assessment of human drugs and biologics applications, Revision 1. FDA Center for Drug Evaluation and Research, Rockville
Fenske M, Maack G, Schafers C, Segner H (2005) An environmentally relevant concentration of estrogen induces arrest of male gonad development in zebrafish, Danio rerio. Environ Toxicol Chem 24:1088–1098
Fent K (2001) Fish cell lines as versatile tools in ecotoxicology: assessment of cytotoxicity, cytochrome P4501A induction potential and estrogenic activity of chemicals and environmental samples. Toxicol In Vitro 15:477–488
Fent K (2007) Ökotoxikologie. Georg Thieme Verlag, Stuttgart
Fent K, Escher C, Caminada D (2006a) Estrogenic activity of pharmaceuticals and pharmaceutical mixtures in a yeast reporter gene system. Reprod Toxicol 22:175–185
Fent K, Weston AA, Caminada D (2006b) Ecotoxicology of human pharmaceuticals. Aquat Toxicol 76:122–159
Ferrari B, Paxeus N, Lo Giudice R, Pollio A, Garric J (2003) Ecotoxicological impact of pharmaceuticals found in treated wastewaters: study of carbamazepine, clofibric acid, and diclofenac. Ecotox Environ Safety 55:359–370
Ferrari B et al. (2004) Environmental risk assessment of six human pharmaceuticals: are the current environmental risk assessment procedures sufficient for the protection of the aquatic environment? Environ Toxicol Chem 23:1344–1354
Flaherty CM, Kashian DR, Dodson SI (2001) Ecological impacts of pharmaceuticals on zooplankton: effects of three medications on Daphnia magna. In: Annual Meeting of the Society of Environmental Toxicology and Chemistry, Baltimore
Fong PP (1998) Zebra mussel spawning is induced in low concentrations of putative serotonin reuptake inhibitors. Biol Bull 194:143–149
Fong PP, Huminski PT, D’Urso LM (1998) Induction and potentiation of parturition in fingernail clams (Sphaerium striatum) by selective serotonin re-uptake inhibitors (SSRIs). J Exp Zool 280:260–264
Foran CM, Weston J, Slattery M, Brooks BW, Duane BH (2004) Reproductive assessment of Japanese Medaka (Oryzias latipes) following a four-week fluoxetine (SSRI) exposure. Arch Environ Contam Toxicol 46:511–517
Gagne F, Blaise C, André C (2006) Occurrence of pharmaceutical products in a municipal effluent and toxicity to rainbow trout (Oncorhynchus mykiss) hepatocytes. Ecotox Environ Safety 64:329–336
Gamprel A, Wilkinson M, Boutilier R (1994) B-Adrenoreceptor in the trout heart: characterisation, quantification and effects of repeated catecholamine exposure. Gen Comp Endocrinol 95:259–272
Gierse JK, Koboldt CM, Walker MC, Seibert K, Isakson PC (1999) Kinetic basis for selective inhibition of cyclo-oxygenases. Biochem J 339:607–614
Gilbert M et al. (2002) Breeding and mortality of oriental white-backed vulture Gyps bengalensis in Punjab Province, Pakistan. Bird Conserv Int 12:311–326
Golet EM, Alder AC, Giger W (2002) Environmental exposure and risk assessment of fluoroquinolone antibacterial agents in wastewater and river water of the Glatt valley watershed, Switzerland. Environ Sci Technol 36:3645–3651
Gravel A, Vijayan MM (2006) Salicylate disrupts interrenal steroidogenesis and brain glucocorticoid receptor expression in rainbow trout. Toxicol Sci 93:41–49
Haider S, Baqri SSR (2000) beta-Adrenoceptor antagonists reinitiate meiotic maturation in Clarias batrachus oocytes. Comp Biochem Phys A 126:517–525
Hallare AV, Kohler HR, Triebskorn R (2004) Developmental toxicity and stress protein responses in zebrafish embryos after exposure to diclofenac and its solvent, DMSO. Chemosphere 56:659–666
Halling-Sørensen B, Nors Nielsen S, Lanzky PF, Ingerslev F, Holten-Lützhøft HC, Jørgensen SE (1998) Occurrence, fate and effects of pharmaceutical substances in the environment-a review. Chemosphere 36:357–393
Hartmann A, Alder AC, Koller T, Widmer RM (1998) Identification of fluoroquinolone antibiotics as the main source of umuC genotoxicity in native hospital wastewater. Environ Toxicol Chem 17:377–382
Heberer T (2002) Occurrence, fate, and removal of pharmaceutical residues in the aquatic environment: a review of recent research data. Toxicol Lett 131:5–17
Henry TB, Kwon J-W, Armbrust KL, Black MC (2004) Acute and chronic toxicity of five selective serotonin reuptake inhibitors in Ceriodaphnia dubia. Environ Toxicol Chem 23:2229–2233
Henschel KP, Wenzel A, Diedrich M, Fliedner A (1997) Environmental hazard assessment of pharmaceuticals. Regul Toxicol Pharm 25:220–225
Hernando MD, Petrovic M, Fernandez-Alba AR, Barcelo D (2004) Analysis by liquid chromatographyelectrospray ionization tandem mass spectrometry and acute toxicity evaluation for beta-blockers and lipid-regulating agents in wastewater samples. J Chromatogr A 1046:133–140
Hess R, Staubli W, Riess W (1965) Nature of hepatomegalic effect produced by ethyl-chlorophenoxyisobutyrate in rat. Nature 208:856
Hirsch R, Ternes T, Haberer K, Kratz KL (1999) Occurrence of antibiotics in the aquatic environment. Sci Total Environ 225:109–118
Hoeger B, Köllner B, Dietrich DR, Hitzfeld B (2005) Water-borne diclofenac affects kidney and gill integrity and selected immune parameters in brown trout (Salmo trutta f. fario). Aquat Toxicol 75:53–64
Hoffman BB, Lefkowitz RJ (1998) Katecholamine, Sympathomimetika und Adrenorezeptor-Antagonisten. In: Goodman and Gilman, Pharmakologische Grundlagen der Arzneimitteltherapie. McGraw Hill Deutsche Ausgabe
Holm JV, Rugge K, Bjerg PL, Christensen TH (1995) Occurrence and distribution of pharmaceutical organic- compounds in the groundwater downgradient of a landfill (Grindsted, Denmark). Environ Sci Technol 29:1415–1420
Huggett DB, Brooks BW, Peterson B, Foran CM, Schlenk D (2002) Toxicity of selected beta adrenergic receptor-blocking pharmaceuticals (β-blockers) on aquatic organisms. Arch Environ Contam Toxicol 43:229–235
Hummel D, Löffler D, Fink G, Ternes T (2006) Simultaneous determination of psychoactive drugs and their metabolites in aqueous matrices by liquid chromatography mass spectrometry. Environ Sci Technol 40:7321–7328
Ibabe A, Grabenbauer M, Baumgart E, Fahimi HD, Cajaraville MP (2002) Expression of peroxisome proliferator-activated receptors in zebrafish (Danio rerio). Histochem Cell Biol 118:231–239
Ibabe A, Herrero A, Cajaraville MP (2005) Modulation of peroxisome proliferator-activated receptors (PPARs) by PPAR[alpha]- and PPAR[gamma]-specific ligands and by 17[beta]-estradiol in isolated zebrafish hepatocytes. Toxicol In Vitro 19:725–735
Isidori M, Lavorgna M, Nardelli A, Parrella A, Previtera L, Rubino M (2005) Ecotoxicity of naproxen and its phototransformation products. Sci Total Environ 348:91–101
Isidori M, Nardelli A, Parella A, Pascarella L, Previtera L (2006) A multispecies study to assess the toxic and genotoxic effect of pharmaceuticals: Furosemide and its photoproduct. Chemosphere 63:785–793
Jacob S, Rett K, Henriksen EJ (1998) Antihypertensive therapy and insulin sensitivity: Do we have to redefine the role of beta-blocking agents? Am J Hypertens 11:1258–1265
Jensen KM et al. (2004) Characterization of responses to the antiandrogen flutamide in a short-term reproduction assay with the fathead minnow. Aquat Toxicol 70:99–110
Jones OA, Voulvoulis N, Lester JN (2002) Aquatic environmental assessment of the top 25 English prescription pharmaceuticals. Water Res 36:5013–5022
Kersten S, Desvergne B, Wahli W (2000) Roles of PPARs in health and disease. Nature 405:421–424
Kliewer SA et al. (1997) Fatty acids and eicosanoids regulate gene expression through direct interactions with peroxisome proliferator-activated receptors alpha and gamma. Proc Natl Acad Sci USA 94:4318–4323
Kolpin DW et al. (2002) Pharmaceuticals, hormones, and other organic wastewater contaminants in U.S. streams, 1999–2000: a national reconnaissance. Environ Sci Technol 36:1202–1211
Kümmerer K (2001) Drugs in the environment: emission of drugs, diagnostic aids and disinfectants into wastewater by hospitals in relation to other sources – a review. Chemosphere 45:957–969
Kümmerer K (ed) (2004) Pharmaceuticals in the environment, 2nd edn. Springer-Verlag, Berlin
Kümmerer K, Steger-Hartmann T, Meyer M (1997) Biodegradability of the anti-tumour agent ifosfamide and its occurrence in hospital effluents and communal sewage. Water Res 31:2705–2710
Kurumbail RG et al. (1997) Structural basis for selective inhibition of cyclooxygenase-2 by anti-inflammatory agents. Nature 385:555
Lönge R, Hutchinson TH, Croudace CP, Siegmund F (2001) Effects of the synthetic estrogen 17 alphaethinylestradiol on the life-cycle of the fathead minnow (Pimephales promelas). Environ Toxicol Chem 20:1216–1227
Laufs U, Liao JK (1998) Post-transcriptional regulation of endothelial nitric oxide synthase mRNA stability by Rho GTPase. J Biol Chem 273:24266–24271
Laville N, Ait-Aissa S, Gomez E, Casellas C, Porcher JM (2004) Effects of human pharmaceuticals on cytotoxicity, EROD activity and ROS production in fish hepatocytes. Toxicology 196:41–55
Leaver MJ, Wright J, George SG (1998) A peroxisomal proliferator-activated receptor gene from the marine flatfish, the plaice (Pleuronectes platessa). Mar Environ Res 46:75–79
Lilius H, Isomaa B, Holmstrom T (1994) A comparison of the toxicity of 50 reference chemicals to freshly isolated rainbow trout hepatocytes and Daphnia magna. Aquat Toxicol 30:47–60
Lundholm CE (1997) DDE-induced eggshell thinning in birds: Effects of p,p’-DDE on the calcium and prostaglandin metabolism of the eggshell gland. Comp Biochem Phys C 118:113–128
MacDonald RL, Olsen RW (1994) GABA A receptor channels. Ann Rev Neurosci 17:569–602
Marques CR, Abrantes N, Goncalves F (2004) Life-history traits of standard and autochthonous cladocerans: I. Acute and chronic effects of acetylsalicylic acid. Environ Toxicol 19:518–526
Meissl H, Ekstrom P (1991) Action of gamma-aminobutyric-acid (GABA) in the isolated photosensory pineal organ. Brain Res 562:71–78
Metcalfe CD, Miao XS, Koenig BG, Struger J (2003) Distribution of acidic and neutral drugs in surface waters near sewage treatment plants in the lower Great Lakes, Canada. Environ Toxicol Chem 22:2881–2889
Mimeault C, Woodhouse AJ, Miao XS, Metcalfe CD, Moon TW, Trudeau VL (2005) The human lipid regulator, gemfibrozil bioconcentrates and reduces testosterone in the goldfish, Carassius auratus. Aquat Toxicol 73:44–54
Mimeault C, Trudeau VL, Moon TW (2006) Waterborne gemfibroil challenges the hepatic antioxidant defense system and down-regulates peroxisome proliferator-activated recepor beta (PPARb) mRNA levels in male goldfish (Carassius auratus). Toxicology 228:140–150
Montforts MHMM, Kalf DF, van Vlaardingen PLA, Linders JBHJ (1999) The exposure assessment for veterinary medicinal products. Sci Total Environ 225:119–133
Nash JP et al. (2004) Long-term exposure to environmental concentrations of the pharmaceutical ethynylestradiol causes reproductive failure in fish. Environ Health Perspect 112:1725–1733
Nation JL (2002) Insect physiology and biochemistry. CRC Press, Boca Raton
Navarro I et al. (1999) Insulin, insulin-like growth factor-I (IGF-I) and glucagon: the evolution of their receptors. Comp Biochem Phys B 122:137–153
Nelson DR et al. (1996) P450 superfamily: Update on new sequences, gene mapping, accession numbers and nomenclature. Pharmacogenetics 6:1–42
Nickerson JG, Dugan SG, Drouin G, Moon TW (2001) A putative beta-adrenoceptor from the rainbow trout (Oncorhynchus mykiss). Molecular charcterisation and pharmacology. Eur J Biochem 268: 6465–6472
Nunes B, Carvalho F, Guilhermino L (2004) Acute and chronic effects of clofibrate and clofibric acid on the enzymes acetylcholinesterase, lactate dehydrogenase and catalase of the mosquitofish, Gambusia holbrooki. Chemosphere 57:1581–1589
Oaks JL et al. (2004) Diclofenac residues as the cause of vulture population decline in Pakistan. Nature 427:630–633
Pagano G et al. (2001) The role of oxidative stress in developmental and reproductive toxicity of tamoxifen. Life Sci 68:1735–1749
Panter GH, Hutchinson TH, Hurd KS, Sherren A, Stanley RD, Tyler CR (2004) Successful detection of (anti-) androgenic and aromatase inhibitors in pre-spawning adult fathead minnows (Pimephales promelas) using easily measured endpoints of sexual development. Aquat Toxicol 70:11–21
Parrott JL, Blunt BR (2005) Life-cycle exposure of fathead minnows (Pimephales promelas) to an ethinylestradiol concentration below 1 ng l–1 reduces egg fertilization success and demasculinizes males. Environ Toxicol 20:131–141
Pascoe D, Karntanut W, Muller CT (2003) Do pharmaceuticals affect freshwater invertebrates? A study with the cnidarian Hydra vulgaris. Chemosphere 51:521–528
Pawlowski S, van Aerle R, Tyler CR, Braunbeck T (2004) Effects of 17α-ethinylestradiol in a fathead minnow (Pimephales promelas) gonadal recrudescence assay. Ecotoxicol Environ Safety 57:330–345
Pedibhotla VK, Sarath G, Sauer JR, Stanleysamuelson DW (1995) Prostaglandin biosynthesis and subcellular- localization of prostaglandin-H synthase activity in the lone star tick, Amblyommaamericanum. Insect Biochem Molec 25:1027–1039
Penning TD et al. (1997) Synthesis and biological evaluation of the 1,5-diarylpyrazole class of cyclooxygenase-2 inhibitors: Identification of 4- 5-(4-methylphenyl)-3-(trifluoromethyl)-1H-pyrazol- 1-yl benzenesulfonamide (SC-58635, Celecoxib). J Med Chem 40:1347–1365
Peraza MA, Burdick AD, Marin HE, Gonzalez FJ, Peters JM (2006) The toxicology of ligands for peroxisome proliferator-activated receptors (PPAR). Toxicol Sci 90:269–295
Qu B, Li Q-T, Wong KP, Tan TMC, Halliwell B (2001) Mechanism of clofibrate hepatotoxicity: mitochondrial damage and oxidative stress in hepatocytes. Free Radical Biol Med 31:659–669
Rang HP, Dale MM, Ritter JM (2003) Pharmacology. Churchill Livingstone
Rau MA, Whitaker J, Freedman JH, Di Giulio RT (2004) Differential susceptibility of fish and rat liver cells to oxidative stress and cytotoxicity upon exposure to prooxidants. Comp Biochem Phys C 137:335–342
Richards SM et al. (2004) Effects of pharmaceutical mixtures in aquatic microcosms. Environ Toxicol Chem 23:1035–1042
Roberts SB, Langenau DM, Goetz FW (2000) Cloning and characterization of prostaglandin endoperoxide synthase-1 and -2 from the brook trout ovary. Mol Cell Endocrin 160:89–97
Rogers CJ, Twyman RE, Macdonald RL (1994) Benzodiazepine and beta-carboline regulation of single GABA A receptor channels of mouse spinal neurones in culture. J Physiol 475:69–82
Ruuskanen JO, Peitsaro N, Kaslin JV, Panula P, Scheinin M (2005) Expression and function of α-adrenoceptors in zebrafish: drug effects, mRNA and receptor distributions. Brti J Pharmacol 144:165–177
Ruyter B, Andersen O, Dehli A, Ostlund Farrants A-K, Gjoen T, Thomassen MS (1997) Peroxisome proliferator activated receptors in Atlantic salmon (Salmo salar): effects on PPAR transcription and acyl-CoA oxidase activity in hepatocytes by peroxisome proliferators and fatty acids. BBA-Lipid Met 1348:331–338
Sanderson H, Johnson DJ, Wilson CJ, Brain RA, Solomon KR (2003) Probabilistic hazard assessment of environmentally occurring pharmaceuticals toxicity to fish, daphnids and algae by ECOSAR screening. Toxicol Lett 144:383–395
Sanderson H, Brain RA, Johnson DJ, Wilson CJ, Solomon KR (2004a) Toxicity classification and evaluation of four pharmaceuticals classes: antibiotics, antineoplastics, cardiovascular, and sex hormones. Toxicology 203:27–40
Sanderson H, Johnson DJ, Reitsma T, Brain RA, Wilson CJ, Solomon KR (2004b) Ranking and prioritization of environmental risks of pharmaceuticals in surface waters. Regul Toxicol Pharm 39:158–183
Scarano LJ, Calabrese EJ, Kostecki PT, Baldwin LA, Leonard DA (1994) Evaluation of a rodent peroxisome proliferator in two species of freshwater fish: rainbow trout (Onchorynchus mykiss) and Japanese medaka (Oryzias latipes). Ecotoxicol Environ Safety 29:13–19
Schalhorn A (1995) Medikamentöse Therapie maligner Erkrankungen. Gustav Fischer Verlag, Stuttgart
Scholze J (1999) Hypertonie – Risikokonstellationen und Begleiterkrankungen. Blackwell
Schoonjans K, Staels B, Auwerx J (1996) Role of the peroxisome proliferator-activated receptor (PPAR) in mediating the effects of fibrates and fatty acids on gene expression. J Lipid Res 37:907–925
Schwaiger J, Ferling H, Mallow U, Wintermayr H, Negele RD (2004) Toxic effects of the non-steroidal anti-inflammatory drug diclofenac. Part I: Histopathological alterations and bioaccumulation in rainbow trout. Aquat Toxicol 68:141–150
Song WC, Brash AR (1991) Purification of an allene oxide synthase and identification of the enzyme as a cytochrome-P-450. Science 253:781–784
Soyka D (1984) Beta-blockers in the prophylactic treatment of migraine and tension headache. Nervenheilkunde 3:85–89
Soyka D (1985) Beta-receptor blockers in migraine. Deut Med Wochenschr 110:185–186
Staels B, Dallongeville J, Auwerx J, Schoonjans K, Leitersdorf E, Fruchart J-C (1998) Mechanism of action of fibrates on lipid and lipoprotein metabolism. Circulation 98:2088–2093
Straub JO (2002) Environmental risk assessment for new human pharmaceuticals in the European Union according to the draft guideline/discussion paper of January 2001. Toxicol Lett 135:231–237
Straub JO, Stewart KM (2007) Deterministic and probabilistic acute-based environmental risk assessment for naproxen for western Europe. Environ Toxicol Chem 26:795–805
Study RE, Barker JL (1981) Diazepam and (-)-pentobarbital: fluctuation analysis reveals different mechanisms for potentiation of gamma-aminobutyric acid responses in cultured central neurons. Proc Natl Acad Sci USA 78:7180–7184
Stumpf M, Ternes T, Haberer K, Seel P, Baumann W (1996) Nachweis von Arzneimittelrückstönden in Klöranlagen und Fliessgewössern. Vom Wasser 86:291–303
Stumpf M, Ternes TA, Wilken R-D, Silvana Vianna Rodrigues, Baumann W (1999) Polar drug residues in sewage and natural waters in the state of Rio de Janeiro, Brazil. Sci Total Environ 225:135–141
Ternes TA (1998b) Occurrence of drugs in German sewage treatment plants and rivers. Water Res 32:3245–3260
Ternes T, Hirsch R, Mueller J, Haberer K (1998a) Methods for the determination of neutral drugs as well as betablockers and alpha2-sympathomimetics in aqueous matrices using GC/MS and LC/MS/MS. Fresen J Anal Chem 362:329–340
Ternes TA, Stumpf M, Mueller J, Haberer K, Wilken R-D, Servos M (1999) Behavior and occurrence of estrogens in municipal sewage treatment plants I. Investigations in Germany, Canada and Brazil. Sci Total Environ 225:81–90
Ternes T, Bonerz M, Schmidt T (2001) Determination of neutral pharmaceuticals in wastewater and rivers by liquid chromatography-electrospray tandem mass spectrometry. J Chromatogr A 938:175–185
Ternes T, Jos A, Siegrist H (2004) Scrutinizing pharmaceutical and personal care products in wastewater treatment. Environ Sci Technol 38:393–399
Thaker (2005) Pharmaceutical data elude researchers. Environ Sci Technol 139:193A–194A
Thomas KV, Hilton MJ (2004) The occurrence of selected human pharmaceutical compounds in UK estuaries. Mar Pollut Bull 49:436–444
Triebskorn R, Casper H, Heyd A, Eikemper R, Kohler H-R, Schwaiger J (2004) Toxic effects of the nonsteroidal anti-inflammatory drug diclofenac: Part II. Cytological effects in liver, kidney, gills and intestine of rainbow trout (Oncorhynchus mykiss). Aquat Toxicol 68:151–166
van der Ven K, Keil D, Van Leemput K, van Remortel P, De Coen WM (2006) Neuropharmaceuticals in the environment: mianserin-induced neuroendocrine disruption in zebrafish (Danio rerio) using cDNA microarrays. Environ Toxicol Chem 25:2645–2652
Vane JR, Botting RM (1998) Mechanism of action of anti-inflammatory drugs. Int J Tissue React 20:3–15
Villegas-Navarro A, Rosas-L E, Reyes JL (2003) The heart of Daphnia magna: effects of four cardioactive drugs. Comp Biochem Phys C 136:127–134
Wallace JL (1997) Nonsteroidal anti-inflammatory drugs and gastroenteropathy: the second hundred years. Gastroenterology 112:1000–1016
Wallace JL, McKnight W, Reuter BK, Vergnolle N (2000) NSAID-induced gastric damage in rats: requirement for inhibition of both cyclooxygenase 1 and 2. Gastroenterology 119:706–714
Webb SF (2001) A data based perspective on the environmental risk assessment of human pharmaceuticals II: aquatic risk characterisation. In: Kümmerer K (ed) Pharmaceuticals in the environment. Sources, fate, effects and risks, 1st edn. Springer-Verlag Berlin, Heidelberg, New York, pp 319–343
Webb SF (2004) A data-based perspective on the environmental risk assessment of human pharmaceuticals I – collation of available ecotoxicity data. In: Kümmerer K (ed) Pharmaceuticals in the environment, 2nd edn. Springer-Verlag, Berlin, Heidelberg, New York, pp 317–343
Weigel S, Kuhlmann J, Huhnerfuss H (2002) Drugs and personal care products as ubiquitous pollutants: occurrence and distribution of clofibric acid, caffeine and DEET in the North Sea. Sci Total Environ 295:131–141
Weigel S, Berger U, Jensen E, Kallenborn R, Thoresen H, Hühnerfuss H (2004) Determination of selected pharmaceuticals and caffeine in sewage and seawater from Tromso/Norway with emphasis on ibuprofen and its metabolites. Chemosphere 56:583–592
Wiegel S et al. (2004) Pharmaceuticals in the river Elbe and its tributaries. Chemosphere 57:107–126
Wilson VS et al. (2004) Cloning and in vitro expression and characterization of the androgen receptor and isolation of estrogen receptor alpha from the fathead minnow (Pimephales promelas). Environ Sci Technol 38:6314–6321
Yang S, Carlson K (2004) Routine monitoring of antibiotics in water and wastewater with a radioimmunoassay technique. Water Res 38:3155–3166
Zou J et al. (1999) Fish macrophages express a cyclo-oxygenase-2 homologue after activation. Biochem J 340:153–159
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2008 Springer-Verlag Berlin Heidelberg
About this chapter
Cite this chapter
Fent, K. (2008). Effects of Pharmaceuticals on Aquatic Organisms. In: Kümmerer, K. (eds) Pharmaceuticals in the Environment. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-540-74664-5_12
Download citation
DOI: https://doi.org/10.1007/978-3-540-74664-5_12
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-540-74663-8
Online ISBN: 978-3-540-74664-5
eBook Packages: Earth and Environmental ScienceEarth and Environmental Science (R0)